2,199
Views
2
CrossRef citations to date
0
Altmetric
Research Article

A novel necroptosis-related gene signature in acute myeloid leukemia

, , &
Article: 2227491 | Received 08 Apr 2023, Accepted 15 Jun 2023, Published online: 27 Jun 2023

References

  • Valk PJ, Verhaak RG, Beijen MA, et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med. 2004;350(16):1617–1628. doi:10.1056/NEJMoa040465
  • Konopleva M, Letai A. BCL-2 inhibition in AML: an unexpected bonus? Blood. 2018;132(10):1007–1012. doi:10.1182/blood-2018-03-828269
  • Galluzzi L, Kepp O, Chan FK, et al. Necroptosis: mechanisms and relevance to disease. Annu Rev Pathol. 2017;12:103–130. doi:10.1146/annurev-pathol-052016-100247
  • Grootjans S, Vanden Berghe T, Vandenabeele P. Initiation and execution mechanisms of necroptosis: an overview. Cell Death Differ. 2017;24(7):1184–1195. doi:10.1038/cdd.2017.65
  • Koo GB, Morgan MJ, Lee DG, et al. Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics. Cell Res. 2015;25(6):707–725. doi:10.1038/cr.2015.56
  • Feng X, Song Q, Yu A, et al. Receptor-interacting protein kinase 3 is a predictor of survival and plays a tumor suppressive role in colorectal cancer. Neoplasma. 2015;62(4):592–601. doi:10.4149/neo_2015_071
  • Gong Y, Fan Z, Luo G, et al. The role of necroptosis in cancer biology and therapy. Mol Cancer. 2019;18(1):100. doi:10.1186/s12943-019-1029-8
  • Hsu SK, Chang T, Lin IL, et al. The role of necroptosis in ROS-mediated cancer therapies and its promising applications. Cancers (Basel). 2020;12(8):2185. doi:10.3390/cancers12082185
  • Strilic B, Yang L, Albarran-Juarez J, et al. Tumour-cell-induced endothelial cell necroptosis via death receptor 6 promotes metastasis. Nature. 2016;536(7615):215–258. doi:10.1038/nature19076
  • Seifert L, Werba G, Tiwari S, et al. The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression. Nature. 2016;532(7598):245–249. doi:10.1038/nature17403
  • Hockendorf U, Yabal M, Herold T, et al. RIPK3 restricts myeloid leukemogenesis by promoting cell death and differentiation of leukemia initiating cells. Cancer Cell. 2016;30(1):75–91. doi:10.1016/j.ccell.2016.06.002
  • Nugues AL, El Bouazzati H, Hetuin D, et al. RIP3 is downregulated in human myeloid leukemia cells and modulates apoptosis and caspase-mediated p65/RelA cleavage. Cell Death Dis. 2014;5:e1384. doi:10.1038/cddis.2014.347
  • Xin J, You D, Breslin P, et al. Sensitizing acute myeloid leukemia cells to induced differentiation by inhibiting the RIP1/RIP3 pathway. Leukemia. 2017;31(5):1154–1165. doi:10.1038/leu.2016.287
  • Degterev A, Hitomi J, Germscheid M, et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol. 2008;4(5):313–321. doi:10.1038/nchembio.83
  • Hockendorf U, Yabal M, Jost PJ. RIPK3-dependent cell death and inflammasome activation in FLT3-ITD expressing LICs. Oncotarget. 2016;7(36):57483–4. doi:10.18632/oncotarget.11195
  • Mouasni S, Tourneur L. FADD at the crossroads between cancer and inflammation. Trends Immunol. 2018;39(12):1036–1053. doi:10.1016/j.it.2018.10.005
  • Chien HT, Cheng S D, Chuang WY, et al. Clinical implications of FADD gene amplification and protein overexpression in Taiwanese oral cavity squamous cell carcinomas. PLoS One. 2016;11(10):e0164870. doi:10.1371/journal.pone.0164870
  • Nakanishi M, Rosenberg DW. Roles of cPLA2alpha and arachidonic acid in cancer. Biochim Biophys Acta. 2006;1761(11):1335–1343. doi:10.1016/j.bbalip.2006.09.005
  • Hassan JJ, Lieske A, Dorpmund N, et al. A multiplex CRISPR-screen identifies PLA2G4A as prognostic marker and druggable target for HOXA9 and MEIS1 dependent AML. Int J Mol Sci. 2021;22(17):9411. doi:10.3390/ijms22179411
  • Masumoto J, Taniguchi S, Ayukawa K, et al. ASC, a novel 22-kDa protein, aggregates during apoptosis of human promyelocytic leukemia HL-60 cells. J Biol Chem. 1999;274(48):33835–8. doi:10.1074/jbc.274.48.33835
  • Deswaerte V, Nguyen P, West A, et al. Inflammasome adaptor ASC suppresses apoptosis of gastric cancer cells by an IL18-mediated inflammation-independent mechanism. Cancer Res. 2018;78(5):1293–1307. doi:10.1158/0008-5472.CAN-17-1887
  • Kuriakose T, Kanneganti TD. ZBP1: innate sensor regulating cell death and inflammation. Trends Immunol. 2018;39(2):123–134. doi:10.1016/j.it.2017.11.002
  • Baik JY, Liu Z, Jiao D, et al. ZBP1 not RIPK1 mediates tumor necroptosis in breast cancer [J]. Nat Commun. 2021;12(1):2666, doi:10.1038/s41467-021-23004-3
  • Sun Y, Wang R, Xie S, et al. A novel identified necroptosis-related risk signature for prognosis prediction and immune infiltration indication in acute myeloid leukemia patients. Genes (Basel). 2022;13(10):1837. doi:10.3390/genes13101837
  • Ma J, Jin Y, Gong B, et al. Pan-cancer analysis of necroptosis-related gene signature for the identification of prognosis and immune significance. Discov Oncol. 2022;13(1):17. doi:10.1007/s12672-022-00477-2